Facetten
Zugriff
Einrichtung
Medientyp
- Text 31
Karte
Erscheinungsjahr
Autor/in
- Bacher, Ulrike
- Kröger, Nicolaus 14
- Zander, Axel R. 13
- Haferlach, Claudia 9
- Ayuketang Ayuk, Francis 8
- alle zeigen
Sprache
- Deutsch 31
31 Einträge gefunden
-
Syngenic graft-versus-chronic-myeloid-leukemia-effect?
2009 - Forschungsinformationssystem des UKE -
-
Gene expression profiling in acute myeloid leukaemia (AML).
2009 - Forschungsinformationssystem des UKE -
-
-
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
- Schnittger, Susanne
- Bacher, Ulrike
- Haferlach, Claudia
- Geer, Thomas
- Müller, Peter
- Mittermüller, Johann
- Petrides, Petro
-
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
- Schafhausen, Philippe
- Dierlamm, Judith
- Bokemeyer, Carsten
- Brümmendorf, Tim
- Bacher, Ulrike
- Zander, Axel R.
- Schnittger, Susanne
-
-
-
Severe aplastic anaemia following leflunomide therapy.
- Wüsthof, Mirjam
- Smirnova, Anna
- Bacher, Ulrike
- Kröger, Nicolaus
- Zander, Axel R.
- Schuch, Gunter
- Bokemeyer, Carsten
-
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
2009 - Forschungsinformationssystem des UKE -
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
- Kröger, Nicolaus
- Zabelina, Tatjana
- Binder, Thomas
- Ayuketang Ayuk, Francis
- Bacher, Ulrike
- Amtsfeld, Gitta
- Lellek, Heinrich
-
RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.
- Schnittger, Susanne
- Bacher, Ulrike
- Kern, Wolfgang
- Tschulik, Claudia
- Weiss, Tamara
- Haferlach, Claudia
- Haferlach, Torsten
-
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.
- Lioznov, Michael
- El-Cheikh, J
- Hoffmann, Friedericke
- Hildebrandt, York
- Ayuketang Ayuk, Francis
- Wolschke, Christine
- Atanackovic, Djordje
-
-
-
-
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.
- Bacher, Ulrike
- Asenova, Svetlana
- Badbaran, Anita
- Zander, Axel R.
- Alchalby, Haefaa
- Fehse, Boris
- Kröger, Nicolaus
-
-
Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.
- Klyuchnikov, Evgeny
- Schafhausen, Philippe
- Kröger, Nicolaus
- Brümmendorf, Tim
- Osanmaz, Okay
- Asenova, Svetlana
- Zabelina, Tatjana